Chemed Co. (NYSE:CHE) Position Cut by Janney Montgomery Scott LLC

Janney Montgomery Scott LLC lessened its stake in shares of Chemed Co. (NYSE:CHE - Free Report) by 13.5% during the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 10,948 shares of the company's stock after selling 1,712 shares during the period. Janney Montgomery Scott LLC owned approximately 0.07% of Chemed worth $5,801,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in the company. HighTower Advisors LLC increased its stake in Chemed by 78.0% during the 3rd quarter. HighTower Advisors LLC now owns 3,730 shares of the company's stock valued at $2,246,000 after purchasing an additional 1,634 shares in the last quarter. XTX Topco Ltd boosted its stake in shares of Chemed by 111.5% during the 3rd quarter. XTX Topco Ltd now owns 2,843 shares of the company's stock worth $1,709,000 after acquiring an additional 1,499 shares in the last quarter. Geode Capital Management LLC grew its holdings in Chemed by 4.9% in the third quarter. Geode Capital Management LLC now owns 335,443 shares of the company's stock valued at $201,820,000 after purchasing an additional 15,791 shares during the period. Signal Advisors Wealth LLC lifted its holdings in Chemed by 60.7% during the fourth quarter. Signal Advisors Wealth LLC now owns 4,995 shares of the company's stock valued at $2,647,000 after purchasing an additional 1,886 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. increased its stake in Chemed by 8.1% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 122,788 shares of the company's stock worth $73,792,000 after buying an additional 9,178 shares in the last quarter. Institutional investors own 95.85% of the company's stock.

Insiders Place Their Bets

In other Chemed news, EVP Spencer S. Lee sold 732 shares of the company's stock in a transaction dated Wednesday, November 27th. The stock was sold at an average price of $575.62, for a total transaction of $421,353.84. Following the completion of the sale, the executive vice president now directly owns 18,287 shares in the company, valued at $10,526,362.94. This represents a 3.85 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, VP Brian C. Judkins acquired 145 shares of the firm's stock in a transaction on Monday, December 30th. The shares were acquired at an average price of $519.50 per share, with a total value of $75,327.50. Following the completion of the purchase, the vice president now owns 1,678 shares of the company's stock, valued at $871,721. This trade represents a 9.46 % increase in their ownership of the stock. The disclosure for this purchase can be found here. 3.32% of the stock is owned by corporate insiders.

Chemed Trading Up 0.8 %

Shares of Chemed stock traded up $4.27 on Thursday, reaching $561.98. 59,119 shares of the stock were exchanged, compared to its average volume of 94,554. Chemed Co. has a 1-year low of $512.12 and a 1-year high of $654.62. The business has a fifty day moving average price of $545.00 and a two-hundred day moving average price of $563.87. The firm has a market capitalization of $8.46 billion, a PE ratio of 28.40, a PEG ratio of 2.15 and a beta of 0.47.

Chemed (NYSE:CHE - Get Free Report) last released its quarterly earnings data on Tuesday, October 29th. The company reported $5.64 EPS for the quarter, missing the consensus estimate of $5.76 by ($0.12). Chemed had a return on equity of 27.86% and a net margin of 12.69%. The business had revenue of $606.18 million during the quarter, compared to analysts' expectations of $612.22 million. During the same quarter in the prior year, the firm earned $5.32 earnings per share. Chemed's quarterly revenue was up 7.4% on a year-over-year basis. Research analysts expect that Chemed Co. will post 21.43 EPS for the current year.

Chemed Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, December 6th. Investors of record on Monday, November 18th were paid a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.36%. The ex-dividend date of this dividend was Monday, November 18th. Chemed's payout ratio is currently 10.11%.

Analyst Upgrades and Downgrades

A number of analysts have issued reports on the company. StockNews.com raised Chemed from a "hold" rating to a "buy" rating in a research report on Saturday, November 30th. Royal Bank of Canada reduced their target price on shares of Chemed from $697.00 to $633.00 and set an "outperform" rating on the stock in a report on Tuesday, November 5th.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.